The Day Hope Got a Name

Two hundred eighty miles doesn’t seem like much until you’re leaving home with no return date. Then it feels like a world away. We traveled in a small caravan: two cars packed to the brim with blankets, toys, and kitchen staples — the small things that might make our temporary apartment feel like home for our five-year-old son. We’d rented it sight unseen, out of necessity. It cost the same as our house payment, but that was a worry for another day.

As the mountains faded in the rearview mirror, silence settled between us. Every mile forward felt like a step away from the life we knew and a step toward something we couldn’t yet imagine. Months of praying, hoping, wishing, fighting with insurance, and pleading with state officials had led us here — to this stretch of highway that felt both endless and holy.

We arrived in the dark, after getting ourselves turned around in the wrong apartment complex. The first thing on our agenda? Putting up a Christmas tree. It was December 17, and in just a few days, our son would be part of something extraordinary. Only a handful of children had gone before him; he would be the second at our clinic to receive the infusion.

A brand-new gene therapy for Duchenne Muscular Dystrophy. A shot in the dark that might alter the course of his life.

ELEVIDYS.

The name itself sounded otherworldly, the kind of word you whispered because it felt fragile. ELEVIDYS. A scientific name, yes, but to us it meant something closer to sacred. It meant the possibility of a future unshaped by fear.

Hope, distilled into a single dose. One infusion that could rewrite the very code of who he was.

It all felt like part of a bigger plan, one we hadn’t written but were meant to follow. Our son was diagnosed on the very day the FDA approved this life-changing treatment. The timing felt too precise to be coincidence, as if God had been drawing the map long before we knew we’d need it—opening doors, placing the right people on our path, all so our son could help pioneer this uncharted territory.

The morning of the infusion, I woke from a restless sleep. My boy was tucked against me, his breath warm and even. I whispered a prayer for the journey we were about to begin.

A long day stretched ahead, one filled with IV pokes, waiting, and the quiet hum of machines. The kind of day where time moves differently, where every sound feels louder, every moment heavier with meaning.

We had endured so much to reach this moment: antibody tests, insurance denials, endless appeals, and a price tag that felt impossible. Every step forward had come with another door to push open, another call to make, another prayer to whisper that this time it would work.

The hospital had to prepare for us, too. A new freezer was installed, one capable of holding ELEVIDYS at nearly ninety degrees below zero. The medicine was flown in from California the day before, guarded like something sacred.

On the morning of treatment, it had to be thawed carefully, then drawn into four enormous syringes. Our son needed two IVs placed, just in case one failed mid-infusion. Each syringe would take forty-five minutes to deliver, every drop carrying the weight of hope and the years of science and research that had made it possible.

In some ways, it didn’t seem fair how quickly everything had fallen into place for us. Soren was diagnosed in June and treated in December of the same year. While other families had spent years waiting for this moment—holding fundraisers, joining trials, paving the way through heartbreak and persistence—our son’s turn came in just a few short months.

I often think about those boys, the ones who came before. The ones who hoped, prayed, and dreamed of a day like this but never got to see it. My son’s story was built on their shoulders, on the strength of families who refused to stop believing that change was possible.

When the nurse entered with the first syringe, tears filled my eyes. The hope and possibility contained in that small vial were everything. The room fell quiet, machines humming softly in the background. The nurse moved with practiced precision, and I felt my life split in two: the one before, and the one we were stepping into now.

I want to make it clear that Duchenne has no cure. This treatment would not erase my son’s diagnosis; it wasn’t even a promise of dramatic change. There were catastrophic side effects we would have to watch for over the next three months. What it offered instead was hope.

Hope that the progression might slow.

Hope that his mobility might improve.

Hope that he could simply remain an active little boy for a few more years.

When the final syringe emptied, we stayed for another two hours for observation. The doctors came in with a long list of possible side effects, emergency numbers to call, and words of cautious reassurance. After hugs and goodbyes, we were finally on our way.

The drive back was quiet, the city lights flickering past the windshield like stars falling in reverse. In the back seat, our son hummed softly to himself, unaware that history had just shifted in his veins.

Three months of weekly appointments followed: blood draws, EKGs, and echocardiograms. There were trips to the park where our son ran faster, jumped higher, and played longer. There were also high-dose steroids that changed his moods, and school days spent behind a computer screen. But still, that day…

That day, hope got a name.

Even now, almost two years later, I can still picture that December day. The golden light through the hospital window, the way his small hand rested in mine. The science behind it all still feels impossible to comprehend, but I know what I saw. I saw a doorway open. I saw faith and science meet in the same room. And for the first time in months, the future didn’t look so scary.